[Genetic tau-variants in patients with frontotemporal dementia]

Psychiatr Prax. 2004 Nov:31 Suppl 1:S55-7. doi: 10.1055/s-2004-828433.
[Article in German]

Abstract

Objective: [corrected] To evaluate tau-associated genetic polymorphisms in patients with sporadic frontotemporal dementia (FTD) and healthy control subjects.

Method: Tau-gene sequence of 30 patients with FTD and 30 healthy controls was analysed by polymerase-chain-reaction (PCR). Subsequent sequencing was performed to identify exonic and intronic differences between both groups.

Results: The following polypmorphisms, which are localized closely to each exon-intron-border, have been identified: In 37 % (n = 11) of the control subjects three different intronic polymorphisms occur simultaneously (Intron 2, 263, C --> Y; Intron 3, 590, A --> R; Intron 11, 150, G --> A). In the FTD group, this coexistance has been observed only in 17 % (n = 5).

Conclusions: In how far there exists a significant correlation between the newly identified triple polymorphism in the Tau gene and an alternated risk for FTD must be evaluated in a lager population. The proximity of these polymorphisms to the exon-intron border would facilitate functional influences on gene expression patterns. These preliminary results described, above potentially point to further pathogenetic factors in the genesis of FTD.

MeSH terms

  • Adult
  • Aged
  • DNA Mutational Analysis
  • Dementia / diagnosis
  • Dementia / genetics*
  • Exons / genetics*
  • Female
  • Genetic Carrier Screening
  • Homozygote
  • Humans
  • Introns / genetics*
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / genetics*
  • Polymorphism, Genetic / genetics*
  • Sequence Analysis, DNA
  • Tauopathies / diagnosis
  • Tauopathies / genetics*
  • tau Proteins

Substances

  • MAPT protein, human
  • Nerve Tissue Proteins
  • tau Proteins